BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Clinical Outcome
28 results:

  • 1. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
    Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
    In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O
    Cordani M; Butera G; Dando I; Torrens-Mas M; Butturini E; Pacchiana R; Oppici E; Cavallini C; Gasperini S; Tamassia N; Nadal-Serrano M; Coan M; Rossi D; Gaidano G; Caraglia M; Mariotto S; Spizzo R; Roca P; Oliver J; Scupoli MT; Donadelli M
    Br J Cancer; 2018 Oct; 119(8):994-1008. PubMed ID: 30318520
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/ MAPK signaling pathway.
    Zhang X; Liu X; Kang S; Liu C; Hao Y
    Cancer Biomark; 2018; 21(4):797-803. PubMed ID: 29286920
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tracking the Evolution of Non-Small-Cell Lung cancer.
    Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
    N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Merkel cell carcinoma: mitoses, expression of Ki-67 and bcl-2 correlate with disease progression.
    Vujic I; Marker M; Posch C; Mühlehner D; Monshi B; Breier F; Steiner A; Ortiz-Urda S; Rappersberger K
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):542-8. PubMed ID: 25088273
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
    Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
    J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Apoptotic markers in photoinduced cutaneous carcinoma.
    Abu Juba B; Şovrea A; Crişan D; Melincovici C; Coneac A; Badea M; Crişan M
    Rom J Morphol Embryol; 2013; 54(3 Suppl):741-7. PubMed ID: 24322021
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrative genomics identifies gene signature associated with melanoma ulceration.
    Rakosy Z; Ecsedi S; Toth R; Vizkeleti L; Hernandez-Vargas H; Lazar V; Emri G; Szatmari I; Herceg Z; Adany R; Balazs M
    PLoS One; 2013; 8(1):e54958. PubMed ID: 23383013
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes.
    Dueñas M; Santos M; Aranda JF; Bielza C; Martínez-Cruz AB; Lorz C; Taron M; Ciruelos EM; Rodríguez-Peralto JL; Martín M; Larrañaga P; Dahabreh J; Stathopoulos GP; Rosell R; Paramio JM; García-Escudero R
    PLoS One; 2012; 7(8):e42494. PubMed ID: 22880004
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
    Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
    Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intratumoral mast cell number is negatively correlated with tumor size and mitosis in dermatofibrosarcoma protuberans.
    Kim M; Cho KH; Lee JH; Chang MS; Cho S
    Exp Dermatol; 2012 Jul; 21(7):559-61. PubMed ID: 22716258
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.
    Schrama D; Peitsch WK; Zapatka M; Kneitz H; Houben R; Eib S; Haferkamp S; Moore PS; Shuda M; Thompson JF; Trefzer U; Pföhler C; Scolyer RA; Becker JC
    J Invest Dermatol; 2011 Aug; 131(8):1631-8. PubMed ID: 21562568
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma.
    Cassarino DS; Cabral ES; Kartha RV; Swetter SM
    Arch Dermatol; 2008 Jan; 144(1):49-56. PubMed ID: 18209168
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
    Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
    Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
    Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
    Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Chromosomal abnormalities, p53 and Bcl-2 expression and clinical outcome in choroidal melanoma.
    Erol N; Oner U; Artan S; Işiksoy S; Yurdakul S
    Melanoma Res; 2004 Dec; 14(6):473-8. PubMed ID: 15577317
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
    Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
    Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
    Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
    J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?
    Feinmesser M; Halpern M; Fenig E; Tsabari C; Hodak E; Sulkes J; Brenner B; Okon E
    Hum Pathol; 1999 Nov; 30(11):1367-72. PubMed ID: 10571519
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.